{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T22:50:47Z","timestamp":1773701447004,"version":"3.50.1"},"reference-count":148,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T00:00:00Z","timestamp":1773619200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T00:00:00Z","timestamp":1773619200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004826","name":"Natural Science Foundation of Beijing Municipality","doi-asserted-by":"publisher","award":["No. 7242230"],"award-info":[{"award-number":["No. 7242230"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Chin Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Ferroptosis is a novel iron-dependent form of programmed cell death characterized by the accumulation of lipid peroxides. Its mechanism involves the disruption of iron metabolism, imbalances in the antioxidant system, and lipid peroxidation. As a leading global cause of death, cancer treatment often faces challenges such as drug resistance and adverse side effects. Traditional Chinese medicine (TCM), as a complementary and alternative therapy, demonstrates significant potential in tumor treatment due to its multi-targeted and multi-pathway regulatory advantages. Recent studies reveal that numerous natural products in Chinese herbal medicines can inhibit tumor growth by inducing ferroptosis. This review systematically elucidates the core molecular mechanisms of ferroptosis, encompassing iron metabolism, lipid peroxidation, and various regulatory pathways. It highlights the research progress on how natural products from TCM induce ferroptosis by regulating key targets in lung cancer, breast cancer, colorectal cancer, gastric cancer, and liver cancer. This review aims to provide a reference for the development of anticancer drugs based on TCM.<\/jats:p>\n                  <jats:p>\n                    <jats:bold>Graphical Abstract<\/jats:bold>\n                  <\/jats:p>","DOI":"10.1186\/s13020-026-01363-7","type":"journal-article","created":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T10:22:02Z","timestamp":1773656522000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Anti-cancer mechanism of traditional Chinese medicine natural products targeting ferroptosis"],"prefix":"10.1186","volume":"21","author":[{"given":"Jiying","family":"Zhou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peiying","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meiling","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaodong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keyan","family":"Chai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haojia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lijia","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yiyan","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiaqi","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chuanqi","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siyun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hua","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peizhi","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiarui","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,16]]},"reference":[{"issue":"5","key":"1363_CR1","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","volume":"149","author":"SJ Dixon","year":"2012","unstructured":"Dixon SJ, Lemberg KM, Lamprecht MR, Skouta R, Zaitsev EM, Gleason CE, et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell. 2012;149(5):1060\u201372.","journal-title":"Cell"},{"issue":"4","key":"1363_CR2","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/s41580-020-00324-8","volume":"22","author":"X Jiang","year":"2021","unstructured":"Jiang X, Stockwell BR, Conrad M. Ferroptosis: mechanisms, biology and role in disease. Nat Rev Mol Cell Biol. 2021;22(4):266\u201382.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"2","key":"1363_CR3","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-2298-2","volume":"11","author":"J Li","year":"2020","unstructured":"Li J, Cao F, Yin HL, Huang ZJ, Lin ZT, Mao N, et al. Ferroptosis: past, present and future. Cell Death Dis. 2020;11(2):88.","journal-title":"Cell Death Dis"},{"issue":"5","key":"1363_CR4","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1038\/s41571-020-00462-0","volume":"18","author":"X Chen","year":"2021","unstructured":"Chen X, Kang R, Kroemer G, Tang D. Broadening horizons: the role of ferroptosis in cancer. Nat Rev Clin Oncol. 2021;18(5):280\u201396.","journal-title":"Nat Rev Clin Oncol"},{"issue":"1","key":"1363_CR5","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-023-01606-1","volume":"8","author":"S Sun","year":"2023","unstructured":"Sun S, Shen J, Jiang J, Wang F, Min J. Targeting ferroptosis opens new avenues for the development of novel therapeutics. Signal Transduct Target Ther. 2023;8(1):372.","journal-title":"Signal Transduct Target Ther"},{"issue":"3","key":"1363_CR6","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363.","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"1363_CR7","first-page":"183","volume":"75","author":"KJ Pienta","year":"2025","unstructured":"Pienta KJ, Goodin PL, Amend SR. Defeating lethal cancer: interrupting the ecologic and evolutionary basis of death from malignancy. CA Cancer J Clin. 2025;75(3):183\u2013202.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"1363_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-01969-z","volume":"9","author":"Q Ru","year":"2024","unstructured":"Ru Q, Li Y, Chen L, Wu Y, Min J, Wang F. Iron homeostasis and ferroptosis in human diseases: mechanisms and therapeutic prospects. Signal Transduct Target Ther. 2024;9(1):271.","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"1363_CR9","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-019-0720-y","volume":"12","author":"Y Mou","year":"2019","unstructured":"Mou Y, Wang J, Wu J, He D, Zhang C, Duan C, et al. Ferroptosis, a new form of cell death: opportunities and challenges in cancer. J Hematol Oncol. 2019;12(1):34.","journal-title":"J Hematol Oncol"},{"issue":"1","key":"1363_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-021-01164-5","volume":"14","author":"S Zhu","year":"2021","unstructured":"Zhu S, Zhang T, Zheng L, Liu H, Song W, Liu D, et al. Combination strategies to maximize the benefits of cancer immunotherapy. J Hematol Oncol. 2021;14(1):156.","journal-title":"J Hematol Oncol"},{"issue":"12","key":"1363_CR11","doi-asserted-by":"publisher","first-page":"1908","DOI":"10.1001\/jamaoncol.2021.5009","volume":"7","author":"TJ Brown","year":"2021","unstructured":"Brown TJ, Mamtani R, Bange EM. Immunotherapy adverse effects. JAMA Oncol. 2021;7(12):1908.","journal-title":"JAMA Oncol"},{"issue":"Suppl 1","key":"1363_CR12","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s40257-018-0384-3","volume":"19","author":"M Lacouture","year":"2018","unstructured":"Lacouture M, Sibaud V. Toxic side effects of targeted therapies and immunotherapies affecting the skin, oral mucosa, hair, and nails. Am J Clin Dermatol. 2018;19(Suppl 1):31\u20139.","journal-title":"Am J Clin Dermatol"},{"issue":"1","key":"1363_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-024-02213-6","volume":"24","author":"S Li","year":"2025","unstructured":"Li S, Chen X, Shi H, Yi M, Xiong B, Li T. Tailoring traditional Chinese medicine in cancer therapy. Mol Cancer. 2025;24(1):27.","journal-title":"Mol Cancer"},{"key":"1363_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2021.105728","volume":"170","author":"S Wang","year":"2021","unstructured":"Wang S, Fu JL, Hao HF, Jiao YN, Li PP, Han SY. Metabolic reprogramming by traditional Chinese medicine and its role in effective cancer therapy. Pharmacol Res. 2021;170:105728.","journal-title":"Pharmacol Res"},{"key":"1363_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/1476-4598-8-21","volume":"8","author":"HS Parekh","year":"2009","unstructured":"Parekh HS, Liu G, Wei MQ. A new dawn for the use of traditional Chinese medicine in cancer therapy. Mol Cancer. 2009;8:21.","journal-title":"Mol Cancer"},{"key":"1363_CR16","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.freeradbiomed.2025.04.052","volume":"235","author":"E Zhang","year":"2025","unstructured":"Zhang E, Wang Y, Zhang H, Li X, Su Y, Cui J, et al. Resveratrol induces ferroptosis in triple-negative breast cancer through NEDD4L-mediated GPX4 ubiquitination and degradation. Free Radic Biol Med. 2025;235:231\u201347.","journal-title":"Free Radic Biol Med"},{"issue":"2","key":"1363_CR17","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1038\/s41401-020-0478-3","volume":"42","author":"ZJ Li","year":"2021","unstructured":"Li ZJ, Dai HQ, Huang XW, Feng J, Deng JH, Wang ZX, et al. Artesunate synergizes with sorafenib to induce ferroptosis in hepatocellular carcinoma. Acta Pharmacol Sin. 2021;42(2):301\u201310.","journal-title":"Acta Pharmacol Sin"},{"issue":"1","key":"1363_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-01769-5","volume":"9","author":"Q Zhou","year":"2024","unstructured":"Zhou Q, Meng Y, Li D, Yao L, Le J, Liu Y, et al. Ferroptosis in cancer: from molecular mechanisms to therapeutic strategies. Signal Transduct Target Ther. 2024;9(1):55.","journal-title":"Signal Transduct Target Ther"},{"issue":"2","key":"1363_CR19","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/s41422-020-00441-1","volume":"31","author":"D Tang","year":"2021","unstructured":"Tang D, Chen X, Kang R, Kroemer G. Ferroptosis: molecular mechanisms and health implications. Cell Res. 2021;31(2):107\u201325.","journal-title":"Cell Res"},{"key":"1363_CR20","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1146\/annurev.physiol.69.031905.164337","volume":"69","author":"NC Andrews","year":"2007","unstructured":"Andrews NC, Schmidt PJ. Iron homeostasis. Annu Rev Physiol. 2007;69:69\u201385.","journal-title":"Annu Rev Physiol"},{"issue":"3","key":"1363_CR21","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/S0092-8674(04)00343-5","volume":"117","author":"MW Hentze","year":"2004","unstructured":"Hentze MW, Muckenthaler MU, Andrews NC. Balancing acts: molecular control of mammalian iron metabolism. Cell. 2004;117(3):285\u201397.","journal-title":"Cell"},{"issue":"1","key":"1363_CR22","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.cell.2010.06.028","volume":"142","author":"MW Hentze","year":"2010","unstructured":"Hentze MW, Muckenthaler MU, Galy B, Camaschella C. Two to tango: regulation of mammalian iron metabolism. Cell. 2010;142(1):24\u201338.","journal-title":"Cell"},{"issue":"1","key":"1363_CR23","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/nchembio.2239","volume":"13","author":"S Doll","year":"2017","unstructured":"Doll S, Proneth B, Tyurina YY, Panzilius E, Kobayashi S, Ingold I, et al. ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition. Nat Chem Biol. 2017;13(1):91\u20138.","journal-title":"Nat Chem Biol"},{"issue":"34","key":"1363_CR24","doi-asserted-by":"publisher","first-page":"E4966","DOI":"10.1073\/pnas.1603244113","volume":"113","author":"WS Yang","year":"2016","unstructured":"Yang WS, Kim KJ, Gaschler MM, Patel M, Shchepinov MS, Stockwell BR. Peroxidation of polyunsaturated fatty acids by lipoxygenases drives ferroptosis. Proc Natl Acad Sci U S A. 2016;113(34):E4966-4975.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"12","key":"1363_CR25","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1038\/s41589-019-0408-1","volume":"15","author":"M Conrad","year":"2019","unstructured":"Conrad M, Pratt DA. The chemical basis of ferroptosis. Nat Chem Biol. 2019;15(12):1137\u201347.","journal-title":"Nat Chem Biol"},{"issue":"3","key":"1363_CR26","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.chembiol.2018.11.016","volume":"26","author":"L Magtanong","year":"2019","unstructured":"Magtanong L, Ko PJ, To M, Cao JY, Forcina GC, Tarangelo A, et al. Exogenous monounsaturated fatty acids promote a ferroptosis-resistant cell state. Cell Chem Biol. 2019;26(3):420-432.e429.","journal-title":"Cell Chem Biol"},{"issue":"20","key":"1363_CR27","doi-asserted-by":"publisher","first-page":"5355","DOI":"10.1158\/0008-5472.CAN-19-0369","volume":"79","author":"L Tesfay","year":"2019","unstructured":"Tesfay L, Paul BT, Konstorum A, Deng Z, Cox AO, Lee J, et al. Stearoyl-CoA desaturase 1 protects ovarian cancer cells from ferroptotic cell death. Cancer Res. 2019;79(20):5355\u201366.","journal-title":"Cancer Res"},{"issue":"13","key":"1363_CR28","doi-asserted-by":"publisher","first-page":"2748","DOI":"10.1016\/j.cell.2023.05.003","volume":"186","author":"D Liang","year":"2023","unstructured":"Liang D, Feng Y, Zandkarimi F, Wang H, Zhang Z, Kim J, et al. Ferroptosis surveillance independent of GPX4 and differentially regulated by sex hormones. Cell. 2023;186(13):2748-2764.e2722.","journal-title":"Cell"},{"issue":"8","key":"1363_CR29","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1007\/s13238-020-00789-5","volume":"12","author":"P Koppula","year":"2021","unstructured":"Koppula P, Zhuang L, Gan B. Cystine transporter SLC7A11\/xCT in cancer: ferroptosis, nutrient dependency, and cancer therapy. Protein Cell. 2021;12(8):599\u2013620.","journal-title":"Protein Cell"},{"issue":"8","key":"1363_CR30","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1016\/j.tips.2024.05.006","volume":"45","author":"J Liu","year":"2024","unstructured":"Liu J, Tang D, Kang R. Targeting GPX4 in ferroptosis and cancer: chemical strategies and challenges. Trends Pharmacol Sci. 2024;45(8):666\u201370.","journal-title":"Trends Pharmacol Sci"},{"key":"1363_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2025.217697","volume":"621","author":"X Xue","year":"2025","unstructured":"Xue X, Wang M, Cui J, Yang M, Ma L, Kang R, et al. Glutathione metabolism in ferroptosis and cancer therapy. Cancer Lett. 2025;621:217697.","journal-title":"Cancer Lett"},{"issue":"7784","key":"1363_CR32","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/s41586-019-1707-0","volume":"575","author":"S Doll","year":"2019","unstructured":"Doll S, Freitas FP, Shah R, Aldrovandi M, da Silva MC, Ingold I, et al. FSP1 is a glutathione-independent ferroptosis suppressor. Nature. 2019;575(7784):693\u20138.","journal-title":"Nature"},{"issue":"7784","key":"1363_CR33","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1038\/s41586-019-1705-2","volume":"575","author":"K Bersuker","year":"2019","unstructured":"Bersuker K, Hendricks JM, Li Z, Magtanong L, Ford B, Tang PH, et al. The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis. Nature. 2019;575(7784):688\u201392.","journal-title":"Nature"},{"issue":"9","key":"1363_CR34","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/j.molmed.2023.05.013","volume":"29","author":"W Li","year":"2023","unstructured":"Li W, Liang L, Liu S, Yi H, Zhou Y. FSP1: a key regulator of ferroptosis. Trends Mol Med. 2023;29(9):753\u201364.","journal-title":"Trends Mol Med"},{"issue":"6","key":"1363_CR35","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1016\/j.cmet.2020.10.011","volume":"32","author":"J Zheng","year":"2020","unstructured":"Zheng J, Conrad M. The metabolic underpinnings of ferroptosis. Cell Metab. 2020;32(6):920\u201337.","journal-title":"Cell Metab"},{"issue":"7860","key":"1363_CR36","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1038\/s41586-021-03539-7","volume":"593","author":"C Mao","year":"2021","unstructured":"Mao C, Liu X, Zhang Y, Lei G, Yan Y, Lee H, et al. DHODH-mediated ferroptosis defence is a targetable vulnerability in cancer. Nature. 2021;593(7860):586\u201390.","journal-title":"Nature"},{"issue":"1","key":"1363_CR37","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1021\/acscentsci.9b01063","volume":"6","author":"VAN Kraft","year":"2020","unstructured":"Kraft VAN, Bezjian CT, Pfeiffer S, Ringelstetter L, M\u00fcller C, Zandkarimi F, et al. GTP cyclohydrolase 1\/tetrahydrobiopterin counteract ferroptosis through lipid remodeling. ACS Cent Sci. 2020;6(1):41\u201353.","journal-title":"ACS Cent Sci"},{"issue":"12","key":"1363_CR38","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1038\/s41589-020-0613-y","volume":"16","author":"M Soula","year":"2020","unstructured":"Soula M, Weber RA, Zilka O, Alwaseem H, La K, Yen F, et al. Metabolic determinants of cancer cell sensitivity to canonical ferroptosis inducers. Nat Chem Biol. 2020;16(12):1351\u201360.","journal-title":"Nat Chem Biol"},{"issue":"7","key":"1363_CR39","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1016\/j.molmed.2016.05.002","volume":"22","author":"S Menegon","year":"2016","unstructured":"Menegon S, Columbano A, Giordano S. The dual roles of NRF2 in cancer. Trends Mol Med. 2016;22(7):578\u201393.","journal-title":"Trends Mol Med"},{"key":"1363_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2019.101107","volume":"23","author":"M Dodson","year":"2019","unstructured":"Dodson M, Castro-Portuguez R, Zhang DD. NRF2 plays a critical role in mitigating lipid peroxidation and ferroptosis. Redox Biol. 2019;23:101107.","journal-title":"Redox Biol"},{"issue":"11","key":"1363_CR41","doi-asserted-by":"publisher","first-page":"2229","DOI":"10.1038\/s41401-024-01336-2","volume":"45","author":"X Jiang","year":"2024","unstructured":"Jiang X, Yu M, Wang WK, Zhu LY, Wang X, Jin HC, et al. The regulation and function of Nrf2 signaling in ferroptosis-activated cancer therapy. Acta Pharmacol Sin. 2024;45(11):2229\u201340.","journal-title":"Acta Pharmacol Sin"},{"issue":"1","key":"1363_CR42","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-021-03042-7","volume":"19","author":"L Feng","year":"2021","unstructured":"Feng L, Zhao K, Sun L, Yin X, Zhang J, Liu C, et al. SLC7A11 regulated by NRF2 modulates esophageal squamous cell carcinoma radiosensitivity by inhibiting ferroptosis. J Transl Med. 2021;19(1):367.","journal-title":"J Transl Med"},{"issue":"1","key":"1363_CR43","doi-asserted-by":"publisher","DOI":"10.1186\/s12929-015-0128-0","volume":"22","author":"LY Chau","year":"2015","unstructured":"Chau LY. Heme oxygenase-1: emerging target of cancer therapy. J Biomed Sci. 2015;22(1):22.","journal-title":"J Biomed Sci"},{"issue":"7","key":"1363_CR44","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/s41577-020-00491-x","volume":"21","author":"NK Campbell","year":"2021","unstructured":"Campbell NK, Fitzgerald HK, Dunne A. Regulation of inflammation by the antioxidant haem oxygenase 1. Nat Rev Immunol. 2021;21(7):411\u201325.","journal-title":"Nat Rev Immunol"},{"issue":"3","key":"1363_CR45","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1152\/physrev.00023.2017","volume":"98","author":"M Yamamoto","year":"2018","unstructured":"Yamamoto M, Kensler TW, Motohashi H. The KEAP1-NRF2 system: a thiol-based sensor-effector apparatus for maintaining redox homeostasis. Physiol Rev. 2018;98(3):1169\u2013203.","journal-title":"Physiol Rev"},{"key":"1363_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2023.102726","volume":"63","author":"S Adinolfi","year":"2023","unstructured":"Adinolfi S, Patinen T, Jawahar Deen A, Pitk\u00e4nen S, H\u00e4rk\u00f6nen J, Kansanen E, et al. The KEAP1-NRF2 pathway: targets for therapy and role in cancer. Redox Biol. 2023;63:102726.","journal-title":"Redox Biol"},{"issue":"1","key":"1363_CR47","doi-asserted-by":"publisher","DOI":"10.1186\/s11658-022-00383-z","volume":"27","author":"Y Li","year":"2022","unstructured":"Li Y, Xu B, Ren X, Wang L, Xu Y, Zhao Y, et al. Inhibition of CISD2 promotes ferroptosis through ferritinophagy-mediated ferritin turnover and regulation of p62-Keap1-NRF2 pathway. Cell Mol Biol Lett. 2022;27(1):81.","journal-title":"Cell Mol Biol Lett"},{"issue":"1","key":"1363_CR48","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a001008","volume":"2","author":"M Olivier","year":"2010","unstructured":"Olivier M, Hollstein M, Hainaut P. TP53 mutations in human cancers: origins, consequences, and clinical use. Cold Spring Harb Perspect Biol. 2010;2(1):a001008.","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"7545","key":"1363_CR49","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nature14344","volume":"520","author":"L Jiang","year":"2015","unstructured":"Jiang L, Kon N, Li T, Wang SJ, Su T, Hibshoosh H, et al. Ferroptosis as a p53-mediated activity during tumour suppression. Nature. 2015;520(7545):57\u201362.","journal-title":"Nature"},{"issue":"8","key":"1363_CR50","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-023-06045-y","volume":"14","author":"Y Liu","year":"2023","unstructured":"Liu Y, Lu S, Wu LL, Yang L, Yang L, Wang J. The diversified role of mitochondria in ferroptosis in cancer. Cell Death Dis. 2023;14(8):519.","journal-title":"Cell Death Dis"},{"issue":"1","key":"1363_CR51","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1023\/A:1021601103096","volume":"8","author":"CG Concannon","year":"2003","unstructured":"Concannon CG, Gorman AM, Samali A. On the role of Hsp27 in regulating apoptosis. Apoptosis. 2003;8(1):61\u201370.","journal-title":"Apoptosis"},{"key":"1363_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2024.101126","volume":"77","author":"Y Zou","year":"2024","unstructured":"Zou Y, Yang A, Chen B, Deng X, Xie J, Dai D, et al. CrVDAC3 alleviates ferroptosis by impeding HSPB1 ubiquitination and confers trastuzumab deruxtecan resistance in HER2-low breast cancer. Drug Resist Updat. 2024;77:101126.","journal-title":"Drug Resist Updat"},{"issue":"45","key":"1363_CR53","doi-asserted-by":"publisher","first-page":"5617","DOI":"10.1038\/onc.2015.32","volume":"34","author":"X Sun","year":"2015","unstructured":"Sun X, Ou Z, Xie M, Kang R, Fan Y, Niu X, et al. HSPB1 as a novel regulator of ferroptotic cancer cell death. Oncogene. 2015;34(45):5617\u201325.","journal-title":"Oncogene"},{"issue":"3","key":"1363_CR54","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1038\/s41556-022-01074-9","volume":"25","author":"E Adriaenssens","year":"2023","unstructured":"Adriaenssens E, Asselbergh B, Rivera-Mej\u00edas P, Bervoets S, Vendredy L, De Winter V, et al. Small heat shock proteins operate as molecular chaperones in the mitochondrial intermembrane space. Nat Cell Biol. 2023;25(3):467\u201380.","journal-title":"Nat Cell Biol"},{"issue":"16","key":"1363_CR55","doi-asserted-by":"publisher","first-page":"R921","DOI":"10.1016\/j.cub.2020.06.081","volume":"30","author":"NM Anderson","year":"2020","unstructured":"Anderson NM, Simon MC. The tumor microenvironment. Curr Biol. 2020;30(16):R921-r925.","journal-title":"Curr Biol"},{"issue":"Suppl","key":"1363_CR56","doi-asserted-by":"publisher","first-page":"S185","DOI":"10.1016\/j.semcancer.2015.03.004","volume":"35","author":"DS Vinay","year":"2015","unstructured":"Vinay DS, Ryan EP, Pawelec G, Talib WH, Stagg J, Elkord E, et al. Immune evasion in cancer: mechanistic basis and therapeutic strategies. Semin Cancer Biol. 2015;35(Suppl):S185-s198.","journal-title":"Semin Cancer Biol"},{"issue":"3","key":"1363_CR57","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/s41573-018-0006-z","volume":"18","author":"RS Riley","year":"2019","unstructured":"Riley RS, June CH, Langer R, Mitchell MJ. Delivery technologies for cancer immunotherapy. Nat Rev Drug Discov. 2019;18(3):175\u201396.","journal-title":"Nat Rev Drug Discov"},{"issue":"8","key":"1363_CR58","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/j.tips.2023.06.005","volume":"44","author":"R Kim","year":"2023","unstructured":"Kim R, Taylor D, Vonderheide RH, Gabrilovich DI. Ferroptosis of immune cells in the tumor microenvironment. Trends Pharmacol Sci. 2023;44(8):542\u201352.","journal-title":"Trends Pharmacol Sci"},{"key":"1363_CR59","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1524711","volume":"16","author":"Y Xu","year":"2025","unstructured":"Xu Y, Ge M, Xu Y, Yin K. Ferroptosis: a novel perspective on tumor immunotherapy. Front Immunol. 2025;16:1524711.","journal-title":"Front Immunol"},{"issue":"7755","key":"1363_CR60","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41586-019-1170-y","volume":"569","author":"W Wang","year":"2019","unstructured":"Wang W, Green M, Choi JE, Gij\u00f3n M, Kennedy PD, Johnson JK, et al. CD8(+) T cells regulate tumour ferroptosis during cancer immunotherapy. Nature. 2019;569(7755):270\u20134.","journal-title":"Nature"},{"issue":"3","key":"1363_CR61","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1038\/s41589-019-0462-8","volume":"16","author":"AA Kapralov","year":"2020","unstructured":"Kapralov AA, Yang Q, Dar HH, Tyurina YY, Anthonymuthu TS, Kim R, et al. Redox lipid reprogramming commands susceptibility of macrophages and microglia to ferroptotic death. Nat Chem Biol. 2020;16(3):278\u201390.","journal-title":"Nat Chem Biol"},{"key":"1363_CR62","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.949835","volume":"13","author":"LG Li","year":"2022","unstructured":"Li LG, Peng XC, Yu TT, Xu HZ, Han N, Yang XX, et al. Dihydroartemisinin remodels macrophage into an M1 phenotype via ferroptosis-mediated DNA damage. Front Pharmacol. 2022;13:949835.","journal-title":"Front Pharmacol"},{"key":"1363_CR63","doi-asserted-by":"publisher","DOI":"10.1016\/j.abb.2024.110051","volume":"758","author":"X Zuo","year":"2024","unstructured":"Zuo X, Lin H, Song Z, Yu B, Zhao C. Antitumor activity of dictamnine against colorectal cancer through induction of ferroptosis and inhibition of M2 macrophage polarization via the MAPK signaling. Arch Biochem Biophys. 2024;758:110051.","journal-title":"Arch Biochem Biophys"},{"key":"1363_CR64","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-025-03593-3","author":"M Caforio","year":"2025","unstructured":"Caforio M, Iacovelli S, Locatelli F, Folgiero V. Inducing ferroptosis to improve cancer therapy: a promising tool for enhancing immunotherapy. J Exp Clin Cancer Res. 2025. https:\/\/doi.org\/10.1186\/s13046-025-03593-3.","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"1363_CR65","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-022-01046-3","volume":"7","author":"W Gao","year":"2022","unstructured":"Gao W, Wang X, Zhou Y, Wang X, Yu Y. Autophagy, ferroptosis, pyroptosis, and necroptosis in tumor immunotherapy. Signal Transduct Target Ther. 2022;7(1):196.","journal-title":"Signal Transduct Target Ther"},{"key":"1363_CR66","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.870178","volume":"13","author":"Z Zhou","year":"2022","unstructured":"Zhou Z, Zhao Y, Chen S, Cui G, Fu W, Li S, et al. Cisplatin promotes the efficacy of immune checkpoint inhibitor therapy by inducing ferroptosis and activating neutrophils. Front Pharmacol. 2022;13:870178.","journal-title":"Front Pharmacol"},{"issue":"16","key":"1363_CR67","doi-asserted-by":"publisher","first-page":"7446","DOI":"10.1158\/0008-5472.CAN-04-4267","volume":"65","author":"Y Huang","year":"2005","unstructured":"Huang Y, Dai Z, Barbacioru C, Sad\u00e9e W. Cystine-glutamate transporter SLC7A11 in cancer chemosensitivity and chemoresistance. Cancer Res. 2005;65(16):7446\u201354.","journal-title":"Cancer Res"},{"issue":"1","key":"1363_CR68","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-29905-1","volume":"13","author":"P Koppula","year":"2022","unstructured":"Koppula P, Lei G, Zhang Y, Yan Y, Mao C, Kondiparthi L, et al. A targetable CoQ-FSP1 axis drives ferroptosis- and radiation-resistance in KEAP1 inactive lung cancers. Nat Commun. 2022;13(1):2206.","journal-title":"Nat Commun"},{"issue":"5","key":"1363_CR69","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.7150\/ijbs.77979","volume":"19","author":"C Zhou","year":"2023","unstructured":"Zhou C, Yu T, Zhu R, Lu J, Ouyang X, Zhang Z, et al. Timosaponin AIII promotes non-small-cell lung cancer ferroptosis through targeting and facilitating HSP90 mediated GPX4 ubiquitination and degradation. Int J Biol Sci. 2023;19(5):1471\u201389.","journal-title":"Int J Biol Sci"},{"issue":"1","key":"1363_CR70","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-020-0149-3","volume":"5","author":"P Chen","year":"2020","unstructured":"Chen P, Wu Q, Feng J, Yan L, Sun Y, Liu S, et al. Erianin, a novel dibenzyl compound in Dendrobium extract, inhibits lung cancer cell growth and migration via calcium\/calmodulin-dependent ferroptosis. Signal Transduct Target Ther. 2020;5(1):51.","journal-title":"Signal Transduct Target Ther"},{"key":"1363_CR71","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2020.153370","volume":"80","author":"JS Lou","year":"2021","unstructured":"Lou JS, Zhao LP, Huang ZH, Chen XY, Xu JT, Tai WC, et al. Ginkgetin derived from Ginkgo biloba leaves enhances the therapeutic effect of cisplatin via ferroptosis-mediated disruption of the Nrf2\/HO-1 axis in EGFR wild-type non-small-cell lung cancer. Phytomedicine. 2021;80:153370.","journal-title":"Phytomedicine"},{"key":"1363_CR72","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2021.111585","volume":"139","author":"CY Wu","year":"2021","unstructured":"Wu CY, Yang YH, Lin YS, Chang GH, Tsai MS, Hsu CM, et al. Dihydroisotanshinone I induced ferroptosis and apoptosis of lung cancer cells. Biomed Pharmacother. 2021;139:111585.","journal-title":"Biomed Pharmacother"},{"key":"1363_CR73","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.jare.2023.08.018","volume":"62","author":"LP Zhao","year":"2024","unstructured":"Zhao LP, Wang HJ, Hu D, Hu JH, Guan ZR, Yu LH, et al. \u03b2-elemene induced ferroptosis via TFEB-mediated GPX4 degradation in EGFR wide-type non-small cell lung cancer. J Adv Res. 2024;62:257\u201372.","journal-title":"J Adv Res"},{"key":"1363_CR74","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2022.154601","volume":"109","author":"L Jiaqi","year":"2023","unstructured":"Jiaqi L, Siqing H, Qin W, di Z, Bei Z, Jialin Y. Andrographolide promoted ferroptosis to repress the development of non-small cell lung cancer through activation of the mitochondrial dysfunction. Phytomedicine. 2023;109:154601.","journal-title":"Phytomedicine"},{"key":"1363_CR75","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2022.146460","volume":"827","author":"M Shao","year":"2022","unstructured":"Shao M, Jiang Q, Shen C, Liu Z, Qiu L. Sinapine induced ferroptosis in non-small cell lung cancer cells by upregulating transferrin\/transferrin receptor and downregulating SLC7A11. Gene. 2022;827:146460.","journal-title":"Gene"},{"key":"1363_CR76","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2022.154411","volume":"106","author":"J Li","year":"2022","unstructured":"Li J, Yuan J, Li Y, Wang J, Xie Q, Ma R, et al. D-borneol enhances cisplatin sensitivity via autophagy dependent EMT signaling and NCOA4-mediated ferritinophagy. Phytomedicine. 2022;106:154411.","journal-title":"Phytomedicine"},{"issue":"5","key":"1363_CR77","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1038\/s41422-022-00614-0","volume":"32","author":"Y Xiao","year":"2022","unstructured":"Xiao Y, Ma D, Yang YS, Yang F, Ding JH, Gong Y, et al. Comprehensive metabolomics expands precision medicine for triple-negative breast cancer. Cell Res. 2022;32(5):477\u201390.","journal-title":"Cell Res"},{"issue":"1","key":"1363_CR78","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2024.101915","volume":"6","author":"Y Liu","year":"2025","unstructured":"Liu Y, Sun Q, Guo J, Yan L, Yan Y, Gong Y, et al. Dual ferroptosis induction in N2-TANs and TNBC cells via FTH1 targeting: a therapeutic strategy for triple-negative breast cancer. Cell Rep Med. 2025;6(1):101915.","journal-title":"Cell Rep Med"},{"key":"1363_CR79","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.jare.2024.09.027","volume":"74","author":"G Huang","year":"2025","unstructured":"Huang G, Cai Y, Ren M, Zhang X, Fu Y, Cheng R, et al. Salidroside sensitizes triple-negative breast cancer to ferroptosis by SCD1-mediated lipogenesis and NCOA4-mediated ferritinophagy. J Adv Res. 2025;74:589\u2013607.","journal-title":"J Adv Res"},{"key":"1363_CR80","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.jare.2024.04.009","volume":"69","author":"N Luo","year":"2025","unstructured":"Luo N, Zhang K, Li X, Hu Y, Guo L. Tanshinone IIA destabilizes SLC7A11 by regulating PIAS4-mediated SUMOylation of SLC7A11 through KDM1A, and promotes ferroptosis in breast cancer. J Adv Res. 2025;69:313\u201327.","journal-title":"J Adv Res"},{"issue":"8","key":"1363_CR81","doi-asserted-by":"publisher","first-page":"2531","DOI":"10.7150\/ijbs.82120","volume":"19","author":"YM Chen","year":"2023","unstructured":"Chen YM, Xu W, Liu Y, Zhang JH, Yang YY, Wang ZW, et al. Anomanolide C suppresses tumor progression and metastasis by ubiquitinating GPX4-driven autophagy-dependent ferroptosis in triple negative breast cancer. Int J Biol Sci. 2023;19(8):2531\u201350.","journal-title":"Int J Biol Sci"},{"key":"1363_CR82","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2025.157074","volume":"146","author":"Y Wu","year":"2025","unstructured":"Wu Y, Li Y, Huang Y, Li Q, Li Z, Lv L, et al. Nobiletin promotes ferroptosis in breast cancer through targeting AKR1C1-mediated ubiquitination and degradation of GPX4. Phytomedicine. 2025;146:157074.","journal-title":"Phytomedicine"},{"key":"1363_CR83","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2024.176620","volume":"974","author":"S Ye","year":"2024","unstructured":"Ye S, Hu X, Sun S, Su B, Cai J, Jiang J. Oridonin promotes RSL3-induced ferroptosis in breast cancer cells by regulating the oxidative stress signaling pathway JNK\/Nrf2\/HO-1. Eur J Pharmacol. 2024;974:176620.","journal-title":"Eur J Pharmacol"},{"key":"1363_CR84","doi-asserted-by":"publisher","DOI":"10.3892\/ijmm.2025.5552","author":"F Li","year":"2025","unstructured":"Li F, Qi Q, Qiao Y, Huang Y, Lu Y, Gu K, et al. Curcumenol inhibits malignant progression and promotes ferroptosis via the SLC7A11\/NF\u2011\u03baB\/TGF\u2011\u03b2 pathway in triple\u2011negative breast cancer. Int J Mol Med. 2025. https:\/\/doi.org\/10.3892\/ijmm.2025.5552.","journal-title":"Int J Mol Med"},{"key":"1363_CR85","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.670224","volume":"12","author":"Y Zhou","year":"2021","unstructured":"Zhou Y, Yang J, Chen C, Li Z, Chen Y, Zhang X, et al. Polyphyllin III-induced ferroptosis in MDA-MB-231 triple-negative breast cancer cells can be protected against by KLF4-mediated upregulation of xCT. Front Pharmacol. 2021;12:670224.","journal-title":"Front Pharmacol"},{"key":"1363_CR86","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2024.156130","volume":"135","author":"S Wu","year":"2024","unstructured":"Wu S, Wu X, Wang Q, Chen Z, Li L, Chen H, et al. Bufalin induces ferroptosis by modulating the 2,4-dienoyl-CoA reductase (DECR1)-SLC7A11 axis in breast cancer. Phytomedicine. 2024;135:156130.","journal-title":"Phytomedicine"},{"issue":"8","key":"1363_CR87","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1038\/s41416-023-02149-6","volume":"128","author":"H Yan","year":"2023","unstructured":"Yan H, Talty R, Aladelokun O, Bosenberg M, Johnson CH. Ferroptosis in colorectal cancer: a future target? Br J Cancer. 2023;128(8):1439\u201351.","journal-title":"Br J Cancer"},{"issue":"3","key":"1363_CR88","first-page":"233","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel RL, Wagle NS, Cercek A, Smith RA, Jemal A. Colorectal cancer statistics, 2023. CA Cancer J Clin. 2023;73(3):233\u201354.","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"1363_CR89","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.tcb.2022.11.003","volume":"33","author":"H Yan","year":"2023","unstructured":"Yan H, Talty R, Johnson CH. Targeting ferroptosis to treat colorectal cancer. Trends Cell Biol. 2023;33(3):185\u20138.","journal-title":"Trends Cell Biol"},{"key":"1363_CR90","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2025.156465","volume":"139","author":"Y Zheng","year":"2025","unstructured":"Zheng Y, Zheng Y, Chen H, Tan X, Zhang G, Kong M, et al. Erianin triggers ferroptosis in colorectal cancer cells by facilitating the ubiquitination and degradation of GPX4. Phytomedicine. 2025;139:156465.","journal-title":"Phytomedicine"},{"key":"1363_CR91","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.freeradbiomed.2023.05.008","volume":"204","author":"Q Miao","year":"2023","unstructured":"Miao Q, Deng WQ, Lyu WY, Sun ZT, Fan SR, Qi M, et al. Erianin inhibits the growth and metastasis through autophagy-dependent ferroptosis in KRAS(G13D) colorectal cancer. Free Radic Biol Med. 2023;204:301\u201312.","journal-title":"Free Radic Biol Med"},{"issue":"8","key":"1363_CR92","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1038\/s41401-024-01258-z","volume":"45","author":"JQ Lai","year":"2024","unstructured":"Lai JQ, Zhao LL, Hong C, Zou QM, Su JX, Li SJ, et al. Baicalein triggers ferroptosis in colorectal cancer cells via blocking the JAK2\/STAT3\/GPX4 axis. Acta Pharmacol Sin. 2024;45(8):1715\u201326.","journal-title":"Acta Pharmacol Sin"},{"issue":"9\u201310","key":"1363_CR93","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1007\/s10495-024-01973-2","volume":"29","author":"Z Shen","year":"2024","unstructured":"Shen Z, Zhao L, Yoo SA, Lin Z, Zhang Y, Yang W, et al. Emodin induces ferroptosis in colorectal cancer through NCOA4-mediated ferritinophagy and NF-\u03bab pathway inactivation. Apoptosis. 2024;29(9\u201310):1810\u201323.","journal-title":"Apoptosis"},{"key":"1363_CR94","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.117529","volume":"180","author":"H Xiao","year":"2024","unstructured":"Xiao H, Chen C, Yuan X, Yang L, Zheng Y, Yuan J, et al. Gingerenone A induces ferroptosis in colorectal cancer via targeting suppression of SLC7A11 signaling pathway. Biomed Pharmacother. 2024;180:117529.","journal-title":"Biomed Pharmacother"},{"key":"1363_CR95","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2024.156224","volume":"136","author":"W Haoyue","year":"2025","unstructured":"Haoyue W, Kexiang S, Shan TW, Jiamin G, Luyun Y, Junkai W, et al. Icariin promoted ferroptosis by activating mitochondrial dysfunction to inhibit colorectal cancer and synergistically enhanced the efficacy of PD-1 inhibitors. Phytomedicine. 2025;136:156224.","journal-title":"Phytomedicine"},{"key":"1363_CR96","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2024.118139","volume":"328","author":"X Ji","year":"2024","unstructured":"Ji X, Chen Z, Lin W, Wu Q, Wu Y, Hong Y, et al. Esculin induces endoplasmic reticulum stress and drives apoptosis and ferroptosis in colorectal cancer via PERK regulating eIF2\u03b1\/CHOP and Nrf2\/HO-1 cascades. J Ethnopharmacol. 2024;328:118139.","journal-title":"J Ethnopharmacol"},{"issue":"4","key":"1363_CR97","doi-asserted-by":"publisher","first-page":"587","DOI":"10.3724\/abbs.2023068","volume":"55","author":"Y Wu","year":"2023","unstructured":"Wu Y, Pi D, Zhou S, Yi Z, Dong Y, Wang W, et al. Ginsenoside Rh3 induces pyroptosis and ferroptosis through the Stat3\/p53\/NRF2 axis in colorectal cancer cells. Acta Biochim Biophys Sin (Shanghai). 2023;55(4):587\u2013600.","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"key":"1363_CR98","doi-asserted-by":"publisher","DOI":"10.1016\/j.tice.2025.102793","volume":"95","author":"Q Zhang","year":"2025","unstructured":"Zhang Q, Xu Z, Liu W, Cheng Z, Ding Y, Xie Y, et al. Gastrodin promotes ferroptosis in CRC cells by inhibiting SKP2 to reduce NCOA4 ubiquitination. Tissue Cell. 2025;95:102793.","journal-title":"Tissue Cell"},{"issue":"1","key":"1363_CR99","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1159\/000518483","volume":"103","author":"M Sekiguchi","year":"2022","unstructured":"Sekiguchi M, Oda I, Matsuda T, Saito Y. Epidemiological trends and future perspectives of gastric cancer in Eastern Asia. Digestion. 2022;103(1):22\u20138.","journal-title":"Digestion"},{"issue":"7","key":"1363_CR100","first-page":"547","volume":"1","author":"A Nomura","year":"1992","unstructured":"Nomura A, Chyou PH, Stemmermann GN. Association of serum ferritin levels with the risk of stomach cancer. Cancer Epidemiol Biomarkers Prev. 1992;1(7):547\u201350.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"6","key":"1363_CR101","doi-asserted-by":"publisher","first-page":"482","DOI":"10.4161\/gmic.26262","volume":"4","author":"TL Cover","year":"2013","unstructured":"Cover TL, Peek RM Jr. Diet, microbial virulence, and Helicobacter pylori-induced gastric cancer. Gut Microbes. 2013;4(6):482\u201393.","journal-title":"Gut Microbes"},{"issue":"4","key":"1363_CR102","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1111\/den.14175","volume":"34","author":"T Kamada","year":"2022","unstructured":"Kamada T, Maruyama Y, Monobe Y, Haruma K. Endoscopic features and clinical importance of autoimmune gastritis. Dig Endosc. 2022;34(4):700\u201313.","journal-title":"Dig Endosc"},{"key":"1363_CR103","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2023.216147","volume":"561","author":"R Zhang","year":"2023","unstructured":"Zhang R, Kang R, Tang D. Ferroptosis in gastrointestinal cancer: from mechanisms to implications. Cancer Lett. 2023;561:216147.","journal-title":"Cancer Lett"},{"issue":"4","key":"1363_CR104","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.7150\/ijbs.80324","volume":"19","author":"C Hu","year":"2023","unstructured":"Hu C, Zu D, Xu J, Xu H, Yuan L, Chen J, et al. Polyphyllin B suppresses gastric tumor growth by modulating iron metabolism and inducing ferroptosis. Int J Biol Sci. 2023;19(4):1063\u201379.","journal-title":"Int J Biol Sci"},{"key":"1363_CR105","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.freeradbiomed.2024.01.002","volume":"213","author":"L Ding","year":"2024","unstructured":"Ding L, Dang S, Sun M, Zhou D, Sun Y, Li E, et al. Quercetin induces ferroptosis in gastric cancer cells by targeting SLC1A5 and regulating the p-Camk2\/p-DRP1 and NRF2\/GPX4 axes. Free Radic Biol Med. 2024;213:150\u201363.","journal-title":"Free Radic Biol Med"},{"key":"1363_CR106","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.114986","volume":"164","author":"J Yuan","year":"2023","unstructured":"Yuan J, Khan SU, Yan J, Lu J, Yang C, Tong Q. Baicalin enhances the efficacy of 5-fluorouracil in gastric cancer by promoting ROS-mediated ferroptosis. Biomed Pharmacother. 2023;164:114986.","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"1363_CR107","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-60920-y","volume":"14","author":"L Shao","year":"2024","unstructured":"Shao L, Zhu L, Su R, Yang C, Gao X, Xu Y, et al. Baicalin enhances the chemotherapy sensitivity of oxaliplatin-resistant gastric cancer cells by activating p53-mediated ferroptosis. Sci Rep. 2024;14(1):10745.","journal-title":"Sci Rep"},{"key":"1363_CR108","doi-asserted-by":"publisher","DOI":"10.1007\/s10120-025-01645-3","author":"X Zhao","year":"2025","unstructured":"Zhao X, Lu S, Yan M, Zhu ZG, Dong F, Yan C. Resveratrol targets mitochondrial USP36-SOD2 to induce autophagy-ferroptosis and inhibit gastric cancer progression. Gastric Cancer. 2025. https:\/\/doi.org\/10.1007\/s10120-025-01645-3.","journal-title":"Gastric Cancer"},{"issue":"2","key":"1363_CR109","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/s10120-024-01574-7","volume":"28","author":"H Wang","year":"2025","unstructured":"Wang H, Lu C, Zhou H, Zhao X, Huang C, Cheng Z, et al. Synergistic effects of dihydroartemisinin and cisplatin on inducing ferroptosis in gastric cancer through GPX4 inhibition. Gastric Cancer. 2025;28(2):187\u2013210.","journal-title":"Gastric Cancer"},{"issue":"1","key":"1363_CR110","doi-asserted-by":"publisher","DOI":"10.1080\/15384047.2023.2284849","volume":"25","author":"Y Wang","year":"2024","unstructured":"Wang Y, Guan WX, Zhou Y, Zhang XY, Zhao HJ. Red ginseng polysaccharide promotes ferroptosis in gastric cancer cells by inhibiting PI3K\/Akt pathway through down-regulation of AQP3. Cancer Biol Ther. 2024;25(1):2284849.","journal-title":"Cancer Biol Ther"},{"key":"1363_CR111","doi-asserted-by":"publisher","DOI":"10.1042\/BSR20201807","author":"Z Guan","year":"2020","unstructured":"Guan Z, Chen J, Li X, Dong N. Tanshinone IIA induces ferroptosis in gastric cancer cells through p53-mediated SLC7A11 down-regulation. 2020. Biosci Rep. https:\/\/doi.org\/10.1042\/BSR20201807."},{"issue":"3","key":"1363_CR112","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2022.13224","volume":"23","author":"L Zhang","year":"2022","unstructured":"Zhang L, Li C, Zhang Y, Zhang J, Yang X. Ophiopogonin B induces gastric cancer cell death by blocking the GPX4\/xCT-dependent ferroptosis pathway. Oncol Lett. 2022;23(3):104.","journal-title":"Oncol Lett"},{"key":"1363_CR113","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2017.00992","volume":"8","author":"B Lu","year":"2017","unstructured":"Lu B, Chen XB, Ying MD, He QJ, Cao J, Yang B. The role of ferroptosis in cancer development and treatment response. Front Pharmacol. 2017;8:992.","journal-title":"Front Pharmacol"},{"issue":"7","key":"1363_CR114","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.1002\/ijc.28159","volume":"133","author":"C Louandre","year":"2013","unstructured":"Louandre C, Ezzoukhry Z, Godin C, Barbare JC, Mazi\u00e8re JC, Chauffert B, et al. Iron-dependent cell death of hepatocellular carcinoma cells exposed to sorafenib. Int J Cancer. 2013;133(7):1732\u201342.","journal-title":"Int J Cancer"},{"issue":"3","key":"1363_CR115","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1038\/s41418-022-00941-0","volume":"29","author":"J Chen","year":"2022","unstructured":"Chen J, Li X, Ge C, Min J, Wang F. The multifaceted role of ferroptosis in liver disease. Cell Death Differ. 2022;29(3):467\u201380.","journal-title":"Cell Death Differ"},{"key":"1363_CR116","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2023.155135","volume":"122","author":"R Yang","year":"2024","unstructured":"Yang R, Gao W, Wang Z, Jian H, Peng L, Yu X, et al. Polyphyllin I induced ferroptosis to suppress the progression of hepatocellular carcinoma through activation of the mitochondrial dysfunction via Nrf2\/HO-1\/GPX4 axis. Phytomedicine. 2024;122:155135.","journal-title":"Phytomedicine"},{"key":"1363_CR117","doi-asserted-by":"publisher","DOI":"10.3892\/ijo.2023.5490","author":"Q Huang","year":"2023","unstructured":"Huang Q, Li J, Ma M, Lv M, Hu R, Sun J, et al. High\u2011throughput screening identification of a small\u2011molecule compound that induces ferroptosis and attenuates the invasion and migration of hepatocellular carcinoma cells by targeting the STAT3\/GPX4 axis. Int J Oncol. 2023. https:\/\/doi.org\/10.3892\/ijo.2023.5490.","journal-title":"Int J Oncol"},{"issue":"4","key":"1363_CR118","first-page":"443","volume":"23","author":"Z Qu","year":"2025","unstructured":"Qu Z, Zeng J, Zeng L, Li X, Zhang F. Esculetin triggers ferroptosis via inhibition of the Nrf2-xCT\/GPx4 axis in hepatocellular carcinoma. Chin J Nat Med. 2025;23(4):443\u201356.","journal-title":"Chin J Nat Med"},{"key":"1363_CR119","doi-asserted-by":"publisher","first-page":"611","DOI":"10.2147\/JHC.S395617","volume":"10","author":"Z Xiu","year":"2023","unstructured":"Xiu Z, Li Y, Fang J, Han J, Li S, Li Y, et al. Inhibitory effects of Esculetin on liver cancer through triggering NCOA4 pathway-mediation ferritinophagy in vivo and in vitro. J Hepatocell Carcinoma. 2023;10:611\u201329.","journal-title":"J Hepatocell Carcinoma"},{"issue":"7","key":"1363_CR120","doi-asserted-by":"publisher","first-page":"4895","DOI":"10.1007\/s00210-023-02916-5","volume":"397","author":"Y Yang","year":"2024","unstructured":"Yang Y, Liu C, Wang M, Cheng H, Wu H, Luo S, et al. Arenobufagin regulates the p62-Keap1-Nrf2 pathway to induce autophagy-dependent ferroptosis in HepG2 cells. Naunyn Schmiedebergs Arch Pharmacol. 2024;397(7):4895\u2013909.","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"1363_CR121","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2025.156840","volume":"143","author":"J Zheng","year":"2025","unstructured":"Zheng J, Liu Y, Zhu F, Liu S, Cai Z, Liu M, et al. Picropodophyllin induces ferroptosis via blockage of AKT\/NRF2\/SLC7A11 and AKT\/NRF2\/SLC40A1 axes in hepatocellular carcinoma as a natural IGF1R inhibitor. Phytomedicine. 2025;143:156840.","journal-title":"Phytomedicine"},{"issue":"9","key":"1363_CR122","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1007\/s00432-024-05878-0","volume":"150","author":"Y Jiang","year":"2024","unstructured":"Jiang Y, Hui D, Pan Z, Yu Y, Liu L, Yu X, et al. Curcumin promotes ferroptosis in hepatocellular carcinoma via upregulation of ACSL4. J Cancer Res Clin Oncol. 2024;150(9):429.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"19","key":"1363_CR123","first-page":"3467","volume":"30","author":"S Han","year":"2022","unstructured":"Han S, Guan L, Li S, Wang MJ, Zhou KX, Xi SM. The mechanism of \u03b1-Hederin induced ferroptosis in hepatoma Bel-7402 cells. J Mod Oncol. 2022;30(19):3467\u201372.","journal-title":"J Mod Oncol"},{"issue":"3","key":"1363_CR124","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1111\/pin.13403","volume":"74","author":"L Chen","year":"2024","unstructured":"Chen L, Sun R, Fang K. Erianin inhibits tumor growth by promoting ferroptosis and inhibiting invasion in hepatocellular carcinoma through the JAK2\/STAT3\/SLC7A11 pathway. Pathol Int. 2024;74(3):119\u201328.","journal-title":"Pathol Int"},{"issue":"6","key":"1363_CR125","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-04927-1","volume":"13","author":"D Wang","year":"2022","unstructured":"Wang D, Tang L, Zhang Y, Ge G, Jiang X, Mo Y, et al. Regulatory pathways and drugs associated with ferroptosis in tumors. Cell Death Dis. 2022;13(6):544.","journal-title":"Cell Death Dis"},{"key":"1363_CR126","doi-asserted-by":"publisher","DOI":"10.3390\/antiox11081564","author":"Z Zhai","year":"2022","unstructured":"Zhai Z, Huang Y, Zhang Y, Zhao L, Li W. Clinical research progress of small molecule compounds targeting Nrf2 for treating inflammation-related diseases. Antioxidants. 2022. https:\/\/doi.org\/10.3390\/antiox11081564.","journal-title":"Antioxidants"},{"key":"1363_CR127","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2025.1615197","volume":"13","author":"W Nan","year":"2025","unstructured":"Nan W, Zhou WM, Zi JL, Shi YQ, Dong YB, Song W, et al. Ferroptosis and bone metabolic diseases: the dual regulatory role of the Nrf2\/HO-1 signaling axis. Front Cell Dev Biol. 2025;13:1615197.","journal-title":"Front Cell Dev Biol"},{"issue":"7","key":"1363_CR128","doi-asserted-by":"publisher","first-page":"2272","DOI":"10.1111\/cas.15378","volume":"113","author":"N Iseda","year":"2022","unstructured":"Iseda N, Itoh S, Toshida K, Tomiyama T, Morinaga A, Shimokawa M, et al. Ferroptosis is induced by lenvatinib through fibroblast growth factor receptor-4 inhibition in hepatocellular carcinoma. Cancer Sci. 2022;113(7):2272\u201387.","journal-title":"Cancer Sci"},{"key":"1363_CR129","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1162087","volume":"14","author":"Y Li","year":"2023","unstructured":"Li Y, Yang Y, Guo T, Weng C, Yang Y, Wang Z, et al. Heme oxygenase-1 determines the cell fate of ferroptotic death of alveolar macrophages in COPD. Front Immunol. 2023;14:1162087.","journal-title":"Front Immunol"},{"issue":"3","key":"1363_CR130","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.celrep.2017.12.077","volume":"22","author":"A Tarangelo","year":"2018","unstructured":"Tarangelo A, Magtanong L, Bieging-Rolett KT, Li Y, Ye J, Attardi LD, et al. p53 suppresses metabolic stress-induced ferroptosis in cancer cells. Cell Rep. 2018;22(3):569\u201375.","journal-title":"Cell Rep"},{"issue":"4","key":"1363_CR131","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s10555-025-10306-x","volume":"44","author":"GX Wei","year":"2025","unstructured":"Wei GX, Zhao YQ, Tang R, Shi HS, Li ZP. Ferroptosis at the intersection of radiotherapy and immunotherapy. Cancer Metastasis Rev. 2025;44(4):89.","journal-title":"Cancer Metastasis Rev"},{"issue":"1","key":"1363_CR132","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-024-03235-0","volume":"43","author":"K Cui","year":"2024","unstructured":"Cui K, Wang K, Huang Z. Ferroptosis and the tumor microenvironment. J Exp Clin Cancer Res. 2024;43(1):315.","journal-title":"J Exp Clin Cancer Res"},{"key":"1363_CR133","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2025.104907","volume":"214","author":"M Ebrahimnezhad","year":"2025","unstructured":"Ebrahimnezhad M, Valizadeh A, Yousefi B. Ferroptosis and immunotherapy: breaking barriers in cancer treatment resistance. Crit Rev Oncol Hematol. 2025;214:104907.","journal-title":"Crit Rev Oncol Hematol"},{"key":"1363_CR134","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1290120","volume":"15","author":"J Zhu","year":"2024","unstructured":"Zhu J, Shen P, Xu Y, Zhang X, Chen Q, Gu K, et al. Ferroptosis: a new mechanism of traditional Chinese medicine for cancer treatment. Front Pharmacol. 2024;15:1290120.","journal-title":"Front Pharmacol"},{"key":"1363_CR135","doi-asserted-by":"publisher","first-page":"2427","DOI":"10.2147\/JHC.S492582","volume":"11","author":"Y Nong","year":"2024","unstructured":"Nong Y, Qin H, Wei L, Wei X, Lv J, Huang X, et al. Oxymatrine inhibits PD-L1 by downregulating IFN-\u03b3 to promote ferroptosis and enhance anti-PD-L1 efficacy in liver cancer. J Hepatocell Carcinoma. 2024;11:2427\u201340.","journal-title":"J Hepatocell Carcinoma"},{"key":"1363_CR136","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.112175","volume":"134","author":"C Ye","year":"2024","unstructured":"Ye C, Yao Z, Wang Y, Zhang C. Asiaticoside promoted ferroptosis and suppressed immune escape in gastric cancer cells by downregulating the Wnt\/\u03b2-catenin pathway. Int Immunopharmacol. 2024;134:112175.","journal-title":"Int Immunopharmacol"},{"issue":"6","key":"1363_CR137","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1016\/j.ccell.2019.04.002","volume":"35","author":"B Hassannia","year":"2019","unstructured":"Hassannia B, Vandenabeele P, Vanden Berghe T. Targeting ferroptosis to iron out cancer. Cancer Cell. 2019;35(6):830\u201349.","journal-title":"Cancer Cell"},{"issue":"9","key":"1363_CR138","doi-asserted-by":"publisher","first-page":"2054","DOI":"10.1080\/15548627.2020.1810918","volume":"17","author":"X Chen","year":"2021","unstructured":"Chen X, Li J, Kang R, Klionsky DJ, Tang D. Ferroptosis: machinery and regulation. Autophagy. 2021;17(9):2054\u201381.","journal-title":"Autophagy"},{"key":"1363_CR139","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.semcancer.2019.03.002","volume":"66","author":"B Zhou","year":"2020","unstructured":"Zhou B, Liu J, Kang R, Klionsky DJ, Kroemer G, Tang D. Ferroptosis is a type of autophagy-dependent cell death. Semin Cancer Biol. 2020;66:89\u2013100.","journal-title":"Semin Cancer Biol"},{"issue":"3","key":"1363_CR140","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1038\/s41573-020-00114-z","volume":"20","author":"AG Atanasov","year":"2021","unstructured":"Atanasov AG, Zotchev SB, Dirsch VM, Supuran CT. Natural products in drug discovery: advances and opportunities. Nat Rev Drug Discov. 2021;20(3):200\u201316.","journal-title":"Nat Rev Drug Discov"},{"key":"1363_CR141","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2021.114068","volume":"229","author":"SR Alizadeh","year":"2022","unstructured":"Alizadeh SR, Ebrahimzadeh MA. Quercetin derivatives: drug design, development, and biological activities, a review. Eur J Med Chem. 2022;229:114068.","journal-title":"Eur J Med Chem"},{"issue":"1","key":"1363_CR142","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1080\/03639045.2016.1226337","volume":"43","author":"Z Lu","year":"2017","unstructured":"Lu Z, Su J, Li Z, Zhan Y, Ye D. Hyaluronic acid-coated, prodrug-based nanostructured lipid carriers for enhanced pancreatic cancer therapy. Drug Dev Ind Pharm. 2017;43(1):160\u201370.","journal-title":"Drug Dev Ind Pharm"},{"key":"1363_CR143","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.biopha.2016.06.001","volume":"83","author":"L Liu","year":"2016","unstructured":"Liu L, Qi XJ, Zhong ZK, Zhang EN. Nanomedicine-based combination of gambogic acid and retinoic acid chlorochalcone for enhanced anticancer efficacy in osteosarcoma. Biomed Pharmacother. 2016;83:79\u201384.","journal-title":"Biomed Pharmacother"},{"issue":"2","key":"1363_CR144","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1166\/jbn.2019.2682","volume":"15","author":"D Zhang","year":"2019","unstructured":"Zhang D, Zhang J, Zeng J, Li Z, Zuo H, Huang C, et al. Nano-Gold loaded with Resveratrol enhance the anti-hepatoma effect of Resveratrol in vitro and in vivo. J Biomed Nanotechnol. 2019;15(2):288\u2013300.","journal-title":"J Biomed Nanotechnol"},{"key":"1363_CR145","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.phymed.2018.01.017","volume":"44","author":"G Bai","year":"2018","unstructured":"Bai G, Zhang T, Hou Y, Ding G, Jiang M, Luo G. From quality markers to data mining and intelligence assessment: a smart quality-evaluation strategy for traditional Chinese medicine based on quality markers. Phytomedicine. 2018;44:109\u201316.","journal-title":"Phytomedicine"},{"key":"1363_CR146","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1431862","volume":"15","author":"M Zhao","year":"2024","unstructured":"Zhao M, Che Y, Gao Y, Zhang X. Application of multi-omics in the study of traditional Chinese medicine. Front Pharmacol. 2024;15:1431862.","journal-title":"Front Pharmacol"},{"issue":"11","key":"1363_CR147","first-page":"2090","volume":"21","author":"B Helli","year":"2021","unstructured":"Helli B, Gerami H, Kavianpour M, Heybar H, Hosseini SK, Haghighian HK. Curcumin nanomicelle improves lipid profile, stress oxidative factors and inflammatory markers in patients undergoing coronary elective angioplasty; a randomized clinical trial. Endocr Metab Immune Disord Drug Targets. 2021;21(11):2090\u20138.","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"issue":"12","key":"1363_CR148","doi-asserted-by":"publisher","first-page":"6596","DOI":"10.1039\/D1FO03746C","volume":"13","author":"A Karimi","year":"2022","unstructured":"Karimi A, Naeini F, Niazkar HR, Tutunchi H, Musazadeh V, Mahmoodpoor A, et al. Nano-curcumin supplementation in critically ill patients with sepsis: a randomized clinical trial investigating the inflammatory biomarkers, oxidative stress indices, endothelial function, clinical outcomes and nutritional status. Food Funct. 2022;13(12):6596\u2013612.","journal-title":"Food Funct"}],"container-title":["Chinese Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13020-026-01363-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13020-026-01363-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13020-026-01363-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T22:03:24Z","timestamp":1773698604000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13020-026-01363-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,16]]},"references-count":148,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1363"],"URL":"https:\/\/doi.org\/10.1186\/s13020-026-01363-7","relation":{"references":[{"id-type":"doi","id":"10.1042\/BSR20201807","asserted-by":"subject"}]},"ISSN":["1749-8546"],"issn-type":[{"value":"1749-8546","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,16]]},"assertion":[{"value":"16 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"86"}}